Skip to main content
. 2021 Oct 29;12:754347. doi: 10.3389/fendo.2021.754347

Table 2.

Association between baseline diabetes status and changes in cognitive Z-scores.

Z-scores Diabetes status Model 1 Model 2
β (95% CI) P-value β (95% CI) P-value
GCF No-Diabetes (n=1023) Ref. Ref.
Prediabetes (n=2429) -0.04 (-0.10, 0.03) 0.277 -0.01 (-0.04, 0.03) 0.756
<5y Diabetes (n=667) -0.12 (-0.20, -0.03) 0.008* -0.04 (-0.09, 0.01) 0.109
≥5y Diabetes (n=684) -0.27 (-0.36, -0.18) <0.001* -0.11 (-0.16, -0.06) <0.001*
MMSE No-Diabetes (n=1187) Ref. Ref.
Prediabetes (n=2786) -0.01 (-0.07, 0.05) 0.749 0.01 (-0.05, 0.06) 0.865
<5y Diabetes (n=847) -0.08 (-0.16, 0.01) 0.054 -0.05 (-0.13, 0.03) 0.209
≥5y Diabetes (n=865) -0.11 (-0.19, -0.02) 0.011* -0.06 (-0.14, 0.02) 0.134
CDT No-Diabetes (n=1189) Ref. Ref.
Prediabetes (n=2788) 0.01 (-0.06, 0.07) 0.874 0.01 (-0.05, 0.07) 0.780
<5y Diabetes (n=846) -0.01 (-0.09, 0.08) 0.843 0.01 (-0.08, 0.09) 0.847
≥5y Diabetes (n=866) -0.09 (-0.18, -0.01) 0.031 -0.06 (-0.14, 0.03) 0.171
DST-f No-Diabetes (n=1072) Ref. Ref.
Prediabetes (n=2526) -0.03 (-0.10, 0.05) 0.474 -0.01 (-0.08, 0.06) 0.725
<5y Diabetes (n=702) -0.08 (-0.17, 0.01) 0.087 -0.06 (-0.15, 0.03) 0.198
≥5y Diabetes (n=716) -0.12 (-0.21, -0.03) 0.012* -0.07 (-0.16, 0.02) 0.126
DST-b No-Diabetes (n=1072) Ref. Ref.
Prediabetes (n=2525) -0.04 (-0.11, 0.03) 0.293 -0.02 (-0.09, 0.04) 0.528
<5y Diabetes (n=702) -0.07 (-0.16, 0.02) 0.116 -0.04 (-0.13, 0.04) 0.349
≥5y Diabetes (n=716) -0.11 (-0.20, -0.02) 0.014* -0.05 (-0.14, 0.04) 0.251
VFT-a No-Diabetes (n=1226) Ref. Ref.
Prediabetes (n=2866) -0.07 (-0.13, -0.01) 0.033 -0.05 (-0.11, 0.01) 0.101
<5y Diabetes (n=870) -0.14 (-0.22, -0.05) 0.001* -0.10 (-0.17, -0.02) 0.018
≥5y Diabetes (n=889) -0.25 (-0.33, -0.16) <0.001* -0.18 (-0.26, -0.10) <0.001*
VFT-p No-Diabetes (n=1227) Ref. Ref.
Prediabetes (n=2865) -0.05 (-0.12, 0.02) 0.149 -0.03 (-0.09, 0.03) 0.348
<5y Diabetes (n=870) -0.13 (-0.21, -0.04) 0.005* -0.08 (-0.16, 0.01) 0.060
≥5y Diabetes (n=889) -0.23 (-0.32, -0.14) <0.001* -0.15 (-0.23, -0.07) <0.001*
TMT-A§ No-Diabetes (n=1226) Ref. Ref.
Prediabetes (n=2862) -0.02 (-0.08, 0.04) 0.512 -0.03 (-0.09, 0.03) 0.323
<5y Diabetes (n=869) 0.08 (0.01, 0.16) 0.037 0.05 (-0.02, 0.13) 0.185
≥5y Diabetes (n=886) 0.20 (0.11, 0.29) <0.001* 0.15 (0.06, 0.23) 0.001*
TMT-B§ No-Diabetes (n=1221) Ref. Ref.
Prediabetes (n=2859) 0.01 (-0.05, 0.07) 0.690 0.01 (-0.06, 0.06) 0.994
<5y Diabetes (n=866) 0.11 (0.03, 0.20) 0.006* 0.08 (0.01, 0.16) 0.039
≥5y Diabetes (n=883) 0.24 (0.15, 0.32) <0.001* 0.17 (0.09, 0.25) <0.001*

<5y diabetes, less than 5 years diabetes duration; ≥5y diabetes, more than 5 years diabetes duration; GCF, Global Cognitive Function; MMSE, Mini-Mental State Examination; CDT, Clock Drawing Test; DST-f, Digit Span Test forward section; DST-b, Digit Span Test backward section; VFT-a, Verbal Fluency Test animal category; VFT-p, Verbal Fluency Test letter “p”; TMT-A, Trail Making Test part A; TMT-B, Trail Making Test part B.

§ Inverse neuropsychological assessment score.

Model 1: adjusted for sex, age (in years), intervention group, and center size (<250; 250-300, 300-400; ≥400).

Model 2: further adjusted for baseline education level (primary school; secondary school; college), civil status (single, divorced or separated; married; widower), physical activity (MET min/week), smoking habits (smoker; former smoker; never smoker), alcohol intake (g/day, adding the quadratic term), 17-point Mediterranean diet score, BMI (kg/m²), hypertension (yes/no), hypercholesterolemia (yes/no), and depressive symptomatology (yes/no).

Beta coefficients were estimated using linear regression models with robust standard errors to account for intracluster correlations.

*Significant association after Benjamini-Hochberg correction.